All Posts:Hackensack Meridian John Theurer Cancer Center
-
Hackensack Meridian John Theurer Cancer Center Treats its First Patient in Innovative Cell Therapy Clinical Trial
Researchers at Hackensack Meridian John Theurer Cancer Center — part of the National Cancer Institute-designated Lombardi Comprehensive Cancer Center at Georgetown University —treated its first patient at the Center in a cutting-edge phase I clinical trial of LYL845, a novel cellular therapy under evaluation for advanced melanoma and other select solid tumors. A type of tumor-infiltrating lymphocyte (TIL) therapy, LYL845 is custom-made from a patient’s cells and designed to help the immune system find and kill cancer cells.
Category: Lombardi Stories
-
John Theurer Cancer Center Physician Co-Authors Clinical Research on Innovative Oral Leukemia Therapy
Researchers at Hackensack Meridian’s John Theurer Cancer Center are part of a published Phase 3 study reporting on the equivalent safety and effectiveness in the oral treatment of blood cancers, such as myelodysplastic syndrome and/or chronic myelomonocytic leukemia, to its previously inpatient, intravenous treatment counterparts. John Theurer Cancer Center is part of the NCI-designated Lombardi Comprehensive Cancer Center at Georgetown University.
Category: Lombardi Stories
-
John Theurer Cancer Center Physician Co-Authors Clinical Research on mRNA Vaccine Intervention Benefits in High-Risk Melanoma
Researchers at Hackensack University Medical Center’s John Theurer Cancer Center (JTCC), a part of the NCI-designated Lombardi Comprehensive Cancer Center at Georgetown University, reported on a novel mRNA vaccine’s delivering improved survival rates in Stage IIIB and IV (metastatic) skin cancer, as part of an ongoing joint-study.
Category: Lombardi Stories
-
Study Shows Sleep Disturbances During the Pandemic Were Similar between Breast Cancer Survivors and Healthy Controls
WASHINGTON (May 2, 2022) — Results from the Thinking and Living with Cancer Study (TLC) showed that the development of sleep disturbances during the early months of the COVID-19 pandemic increased symptoms of depression and anxiety among older women, but the findings did not differ between women who survived breast cancer and women without cancer. […]
Category: News Release
-
Small Numbers of Cells in a Tumor Could Be Key Enablers of Cancer Metastasis
WASHINGTON (June 16, 2021) — Just a small number of cells found in tumors can enable and recruit other types of cells nearby, allowing the cancer to spread to other parts of the body, report Georgetown Lombardi Comprehensive Cancer Center scientists. Working with their research collaborators, the scientists found that “enabler cells” comprise about 20 […]
Category: News Release
-
Immunotherapy Combo Halts Rare, Stage 4 Sarcoma in Teen
NUTLEY, NJ (October 14, 2020) — A patient with end-stage and rapidly progressing soft-tissue cancer whose tumor did not respond to standard treatment had a “rapid and complete response” to a novel combination of immunotherapy, according to new research published by a team of scientists from John Theurer Cancer Center at Hackensack University Medical Center […]
Category: News Release